Jiangsu Hengrui Medicine Co., Ltd.

This study tests a new drug called FH-006 combined with other cancer treatments for people with advanced non-small cell lung cancer. The goal is to find the best dose and see if it helps shrink tumors. About 200 adults aged 18-75 with measurable tumors and good organ function can…

This study tests a new drug called SHR-A1811 against a standard combination of chemotherapy and targeted drugs for women with early-stage or locally advanced HER2-positive breast cancer. About 740 women will receive either the new drug or the standard treatment before surgery. Th…

This study tests two experimental drugs (HS-20093 or SHR2554) combined with standard hormone therapy in men with metastatic prostate cancer. The goal is to see if these combinations are safe and can lower PSA levels or slow cancer growth. About 218 men aged 18 to 80 with advanced…

This early-stage study tests a new drug called HRS-2329 in people with advanced solid tumors that have specific RAS gene mutations or amplifications. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. About 120 adults aged 18-75 …

This study tests a new drug called FH-006 in women with advanced solid tumors that have not responded to standard treatments. The goal is to find the safest dose and see if it can shrink tumors or slow disease progression. About 200 participants will be enrolled across multiple c…

This study tests a new drug, HRS-9190, against a standard muscle relaxant used during general anesthesia. About 60 adults having planned surgery will take part. The goal is to see how quickly muscle function returns after the drug is stopped, and to check for side effects.

This early-stage study tests a new drug called HRS-7172 in 120 adults with advanced solid tumors that have RAS mutations or amplifications. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. Researchers will also watch for signs …

This early-stage study tests a new injectable drug called SHR-3167 in 55 adults with type 2 diabetes. The goal is to measure how the drug behaves in the body and how well it controls blood sugar. Participants will be monitored for side effects and hypoglycemic events. The study i…

This study is testing a painkiller called bupivacaine liposome injection for children aged 6 to 17 after orthopedic (bone) surgery. The goal is to see if it safely controls pain and reduces the need for stronger opioid pain medicines. About 232 children will take part, and resear…